SCHEMBL7570634

SCHEMBL7570634

Cc1ccn[c]c1-c1ccccc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 3/20 0.39
MAPK1 P28482 3/20 0.39
HSD17B10 Q99714 5/20 0.38
IDO1 P14902 2/20 0.38
HPGD P15428 5/20 0.37
MAPT P10636 5/20 0.37
NFKB1 P19838 2/20 0.37
RAB9A P51151 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
MEN1 O00255 2/20 0.37
TSHR P16473 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8473218 0.77 HPGD (0.53) SMN1; SMN2ALDH1A1KMT2AHSD17B10IDO1
SCHEMBL7572110 0.73 KDM1A (0.40) SMN1; SMN2ALDH1A1MAPK1HSD17B10HPGD
SCHEMBL7576190 0.73 IDO1 (0.38) SMN1; SMN2ALDH1A1MAPK1HSD17B10IDO1
SCHEMBL7576499 0.69 IKBKB (0.34) SMN1; SMN2KMT2AIDO1MEN1
SCHEMBL3751745 0.68 IDO1 (0.41) SMN1; SMN2ALDH1A1KMT2AMAPK1HSD17B10
SCHEMBL26104342 0.68 CYP17A1 (0.48) SMN1; SMN2KMT2AIDO1HPGDMAPT
SCHEMBL1854469 0.68
SCHEMBL10439544 0.66 MAPK1 (0.61) SMN1; SMN2ALDH1A1KMT2AMAPK1HSD17B10
SCHEMBL3751748 0.66 BACE1 (0.38) SMN1; SMN2ALDH1A1KMT2AMAPK1HSD17B10
SCHEMBL10034853 0.66 MAPK1 (0.61) SMN1; SMN2ALDH1A1KMT2AMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002089799-A2 USE OF DIHYDROPYRAZOLES TO INCREASE ERYTHROPOIETIN AND VASCULARI ZATION THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO disclosed